9 March 2023 - Following the Biden administration’s progress towards lowering prescription drug prices with Medicare price negotiations, some industry advocates want Congress to go a step farther and close patent loopholes which prevent generic varieties of top-selling drugs.

“What we’ve been seeing lately is that companies are filing for dozens or even hundreds of patents to extend their monopoly period in order to keep their revenues, and that’s blocking competition from the market,” Priti Krishtel, co-founder of medicine access nonprofit I-MAK, said.

Read The Hill article